KidneyFuture at the Rare & Genetic Kidney Disease Summit
KidneyFuture's Vincent Ko spoke at the 6th Annual Rare & Genetic Kidney Disease Drug Development Summit in Boston, making the case for runnable CAKUT trials.

KidneyFuture's Vincent Ko spoke at the 6th Annual Rare & Genetic Kidney Disease Drug Development Summit in Boston, making the case for runnable CAKUT trials.

KidneyFuture convenes the TRACK Consortium, a partnership with the FDA, NIH, and researchers worldwide working to better understand congenital kidney disease and bring forward new therapies.

In April, KidneyFuture convened a landmark summit at the FDA campus, bringing together leading researchers, doctors, clinicians, and regulators to advance treatments for congenital kidney disease.